ÀǾàÇ° ¼ººÐ ¸®ºä | ȲÀº°æ ¾à»ç(ºÎ»ê ¿À°Å¸®¾à±¹)
L-¾Æ½ºÆĸ£Æ®»ê-L-¾Æ¸£±â´Ñ°ú ³ëº§»óÀº ¾î¶² »ó°ü°ü°è°¡ ÀÖÀ»±î? ÃÖ±Ù ÀÌ °°Àº ¼ººÐÀ» ÇÔÀ¯ÇÑ ÀϹÝÀǾàÇ°, ¶ó¶ó¿Ã¶ó¶ó´Â Á¦Ç°ÀÌ ¾à±¹ Áø¿´ë¿¡ ¿Ã¶ú´Ù.
1998³â ·Î¹öÆ® F ÆÛÄ¡°íÆ®¿Í ·çÀ̽º À̱׳ª·Î¿Í Æ丮µå ¹Â¶óµå°¡ ³ëº§ »ý¸®ÇлóÀ» °øµ¿ ¼ö»óÇß´Ù. ½ÉÇ÷°ü°è ½ÅÈ£Àü´Þ ºÐÀÚ·Î NO (nitric oxide, »êÈÁú¼Ò)¸¦ ¹ß°ßÇÑ °ø·Î¸¦ ÀÎ Á¤ ¹ÞÀº °ÍÀÌ´Ù. 20³â¼¼¿ù À̵éÀº Ç÷°ü±ÙÀ°¼¼Æ÷¸¦ À̿ϽÃÅ°´Â Ç÷°ü³»ÇǼ¼Æ÷¿¡¼ »ý¼ºµÇ´Â Ç÷°üÀÌ¿Ï¿äÀÎ (Endothelium-derived relaxing factor, EDRF)À» ¹ß°ßÇß°í, ÀÌ EDRF°¡ ±âüÀÎ "NO"À̸ç ÀÎü¿¡¼ È£¸£¸óÀÌ ¾Æ´Ñ ±âü°¡ ½ÅÈ£ Àü´Þ ¹°Áú·Î ÀÛ¿ëÇÏ´Â »õ ¿ø¸®¸¦ ¹àÇô³»¾ú´Ù.
¹Â¶óµå´Â ´ÏÆ®·Î±Û¸®¼¼¸°¿¡¼ À¯¸®µÈ NO°¡ ¼¼Æ÷Áú ³» guanylate cyclase¸¦ È°¼ºÈ½ÃÄÑ cGMP³óµµ¸¦ Áõ°¡½ÃÅ°°í ½ÉÀå Ç÷°ü ÆòÈ°±ÙÀ» À̿ϽÃÄÑ Çù½ÉÁõ¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Ù´Â »ç½ÇÀ» , ÆÛÄ¡ÄÚÆ®´Â Ç÷°ü³»ÇǼ¼Æ÷ÀÇ ±â´ÉÀÌ »ì¾Æ ÀÖ´Â °æ¿ì ¾Æ¼¼Ä¥Äݸ° µî¿¡ ÀÇÇØ EDRF°¡ »ý¼ºµÇ¸é Ç÷°ü ÆòÈ°±ÙÀÌ À̿ϵȴٴ »ç½ÇÀ», À̱׳ª·Î´Â EDRF¸¦ ÀÛµ¿½ÃÅ°´Â ¹°ÁúÀÌ Ã¼³»¿¡¼ »ý¼ºµÇ´Â NOÀÓÀ» ¹àÇû´Ù.
NO´Â ȦÀüÀÚÀÇ ÀÚÀ¯¶óµðÄ®À» °¡Áö°í ÀÖ¾î ¹ÝÀÀ¼ºÀÌ ÀÖÀ¸¸ç ¹°¿¡ ¾à°£ ³ìÀ¸¹Ç·Î Á¶Á÷À¸·Î ºü¸£°Ô È®»êµÇ¾î ¿©·¯ °¡Áö ´Ù¾çÇÑ ¿ªÇÒÀ» ¼öÇàÇÒ ¼ö ÀÖ´Ù.
¡ã [±×¸² 1] Ç÷°ü³»ÇǼ¼Æ÷¿¡¼ÀÇ NO »ý¼º°ú Ç÷°ü ÆòÈ°±Ù ÀÌ¿Ï [A]
ÀÌÈÄ À̱׳ª·Î´Â NO °¡½º¸¦ ¸¶½Ã±âº¸´Ù ¾Æ¸£±â´Ñ °æ±¸ ¼·Ã븦 ÅëÇØ Ã¼³» NO»ý¼ºÀ» µ½´Â °ÍÀÌ °Ç°À» À¯ÁöÇÏ´Â ±æÀ̶ó´Â ³»¿ëÀÇ °¿¬À» Çѱ¹¿¡¼µµ µÎ Â÷·Ê ÇÑ ÀûÀÌ ÀÖ´Ù.[B]
[±×¸² 2]¿¡¼ º¸µíÀÌ NO´Â Çص¶À» À§ÇÑ °£ÀÇ urea cycle¿¡¼µµ »ý¼ºÀÌ µÈ´Ù. ÀÌ urea cycleÀÌ ¿øÈ°È÷ µ¹¾Æ°¡±â À§Çؼ´Â ¾Æ¸£±â´Ñ°ú ÇÔ²² ¾Æ½ºÆĸ£Æ®»êµµ ÇÊ¿äÇÏ´Ù. ÀÌ ¾Æ½ºÆĸ£Æ®»êÀº ¿¡³ÊÁö¸¦ »ý¼ºÇÏ´Â crebsȸ·ÎÀÇ Çʼö ¹°ÁúÀ̱⵵ Çѵ¥ urea cycleÀ» ÅëÇÑ ¾Ï¸ð´Ï¾ÆÀÇ Á¦°Å, ÇǷο¡ ´ëÇÑ ÀúÇ×¼º Áõ°¡, Áö±¸·Â Áõ°¡¸¦ À§ÇØ ¾²ÀδÙ. purineÀÇ Àü±¸Ã¼·Î¼ ÇÙ»ê ÇÕ¼º¿¡ ¾²À̱⵵ ÇÑ´Ù.
¡ã [±×¸² 2] urea cycle and krebs cycle [C]
[±×¸² 1]ÀÇ eNOSó·³ NO¸¦ »ý¼ºÇϱâ À§Çؼ´Â NOS¶ó´Â È¿¼Ò°¡ ÇÊ¿äÇѵ¥ 3°¡ÁöÀÇ ¼ºêÇüÅ°¡ ÀÖ¾î °¢±â ´Ù¸¥ ¿ªÇÒÀ» ÇÑ´Ù. eNOS(endothelial NOS)¿Í nNOS(neuronal NOS), ºÐºñ °¡´ÉÇÑ ÇüÅÂÀÇ iNOS(¸é¿ª¹ÝÀÀ¿¡ ¿¬°ü, Ä®¸ðµÑ¸° °áÇÕÀ¸·Î ¸¹Àº ¾çÀÇ NO¸¦ »ý¼ºÇÏ¿© ¸é¿ª ´ã´ç)°¡ ÀÖ´Ù. ÀÌ eNOS, nNOS, iNOS´Â óÀ½¿¡ °¢°¢ Ç÷°ü³»ÇǼ¼Æ÷, ½Å°æ¼¼Æ÷, ´ë½Ä¼¼Æ÷¿¡¼ ¹ß°ßµÇ¾úÁö¸¸ ½ÇÁ¦·Î´Â ´Ù¾çÇÑ ¼¼Æ÷³ª Á¶Á÷¿¡ ºÐÆ÷µÇ¾î ÀÖ´Ù.[D]
¸é¿ª°è(iNOS ÀÛ¿ë)¿¡¼´Â Ç×¾Ï ¹× Ç׹̻ý¹° ÀÛ¿ë, ½Å°æ°è(nNOS ÀÛ¿ë)¿¡¼´Â ½Å°æÀü´Þ¹°Áú, ¼øȯ±â°è(eNOS ÀÛ¿ë)¿¡¼´Â Ç÷°üÈ®Àå¹°Áú·Î ÀÌÇØÇÏ¸é µÇ´Âµ¥ Ç÷°üÀúÇ×(Áï, Ç÷¾Ð)À» Á¶ÀýÇÏ°í, Àν¶¸°ºÐºñ, ±âµµÀúÇ×, ¿¬µ¿¿îµ¿, ±×¸®°í Ç÷°ü»ý¼º°ú ½Å°æ°èÀÇ ¹ß»ý, ±â¾ï µî¿¡ °ü¿©ÇÑ´Ù.
[NOÀÇ ¿ªÇÒ]
Á» ´õ Á¤È®È÷ ¾à±¹¿¡¼ ¾Æ¸£±â´ÑÀ» Åõ¿©Çϱâ À§ÇØ ÇÊ¿äÇÑ ¿Ü±¹ ¹®Çå ¸î ÆíÀ» ¼Ò°³ÇÑ´Ù.
1. Ç÷°ü³»ÇǼ¼Æ÷ÀÇ ±â´ÉÀÌ Á¤»óÀÎ °æ¿ì [E] NO »ý¼ºÀÇ À¯ÀÏÇÑ ±âÁúÀÎ ¾Æ¸£±â´Ñ ¼·Ãë·Î Ç÷°ü ½ÉÀå°èÀÇ Ç×»ó¼ºÀÌ À¯ÁöµÇ¾ú°í µ¿¹°½ÇÇè¿¡¼ Ç÷¼ÒÆÇ°ú Ç÷¾×ÀÀ°í ½Ã½ºÅÛ¿¡ ¿µÇâÀ» ÁÖ¾ú´Ù.
2. ¾Æ¸£±â´Ñ Åõ¿©´Â[F] °ú´ÙÇÑ È°¼º»ê¼Ò ¾ïÁ¦·Î I/R injury (±¹¼ÒºóÇ÷/Àç°ü·ù¼Õ»ó)¿¹¹æ È¿°ú°¡ ÀÖ´Ù.
3. ¿îµ¿¼±¼ö¿¡°Ô Áö¼ÓÀûÀ¸·Î L-arginine-L- aspartate¸¦ Åõ¿©Çϸé Áö¹æ»ê »êȸ¦ ÃËÁøÇÏ°í Á¥»êÃàÀûÀ» ÁÙÀ̸ç ÃÑ»ê¼Ò ¼Òºñ¸¦ °¨¼Ò½ÃÅ°°í ¿îµ¿ È¿À²À» ³ôÀδÙ.[G]
4. ¿îµ¿Áß ¾Æ¸£±â´Ñ °ø±ÞÀº[H] ±ÙÀ°ÀÇ Æ÷µµ´ç ÀÌ¿ëÀ» Áõ°¡½ÃÅ°°í Áö¹æ»êÀÇ »êȸ¦ ÃËÁø½ÃŲ´Ù.
5. Àå±â°£ÀÇ ¾Æ¸£±â´Ñ ¼·Ãë´Â[I] Á÷°æÀÌ ÀÛÀº °ü»óµ¿¸Æ ³»ÇǼ¼Æ÷ ±â´ÉÀ» Çâ»ó½ÃŲ´Ù.
6. °í¿ë·®ÀÇ ¾Æ¸£±â´Ñ °æ±¸Åõ¿©´Â[J] ¹ß±âºÎÀü¿¡ È¿°ú°¡ ÀÖ´Ù. 60³â´ëºÎÅÍ À¯·´¿¡¼´Â ³²¼º ºÒÀÓ, ¹ß±âºÎÀü¿¡ ´ëÇÑ ¾Æ¸£±â´Ñ °ü·Ã ¿¬±¸°¡ Áö¼ÓµÇ¾î ¿Ô´Ù.
±¹³» ¹®Çåµµ »êÈÁú¼Ò¸¦ Å°¿öµå·Î È®ÀÎÇغ¸¸é Á¤¸» ´Ù¾çÇÑ ¿ëµµ·Î ÀÌ¿ëµÇ´Â °ÍÀ» ¾Ë ¼ö ÀÖ´Ù. ¾Æ¸£±â´Ñ ÇÑ °¡Áö º¹¿ëÀ¸·Î 3°¡ÁöÀÇ ¿ªÇÒÀ» ÇÒ ¼ö Àֱ⠶§¹®ÀÌ´Ù.
Ãâó¿Í °¢ÁÖ
[A] page 501"; name_="Myocardial Oxygen Supply and Demand Relationship: Zipes: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine"
[B] [»ç¶÷»ç¶÷] ³ëº§ ÀÇÇлó ¹ÞÀº ·çÀ̽º À̱׳ª·Î ±³¼ö Áß¾ÓÀϺ¸ 2004.11.21
[C} NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome Christopher W. Armstrong ¿Ü5ÀÎ, Clinica Chimica Acta 413 (2012) 1525–.1531
[D] Synthesis of Nitric Oxide¿¡¼ ¹ßÃé http://www.reading.ac.uk/nitricoxide/intro/no/synthesis.htm
[E] L-arginine and cardiovascular system
[F] L-Arginine Treatment Alters the Kinetics of Nitric Oxide and Superoxide Release and Reduces Ischemia/Reperfusion Injury in Skeletal Muscle
[G} THE PROLONGED INTAKE OF L-ARGININE-L-ASPARTATE REDUCES BLOOD LACTATE ACCUMULATION AND OXYGEN CONSUMPTION DURING SUBMAXIMAL EXERCISE
[H] L-Arginine infusion increases glucose clearance during prolonged exercise in humans
[I} Long-term L-Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans
[K] Effect of oral administration of high-dose nitric oxide donor l-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study